<DOC>
	<DOCNO>NCT01117649</DOCNO>
	<brief_summary>The purpose study investigate efficacy target control fluid therapy hyper-oncotic balanced HES solution compare iso-oncotic HES solution patient undergo elective surgery pancreatic head . A third group receive balance electrolyte solution ( without colloidal volume replacement ) serve control descriptive analysis .</brief_summary>
	<brief_title>Plasma Volume Replacement ( PVR ) Therapy With Colloid Crystalloid Solutions</brief_title>
	<detailed_description />
	<mesh_term>Pharmaceutical Solutions</mesh_term>
	<criteria>Inclusion : patient schedule undergo elective surgery pancreatic head patient willing give voluntary consent participate study , follow full explanation nature purpose study , sign informed consent form approve Institutional Ethics Committee ( IEC ) prior evaluation . Exclusion : patient American Society Anesthesiologists ( ASA ) class &gt; III heart failure define New York Heart Association ( NYHA ) class &gt; 2 aneurysm ascend thoracic aorta patient Zenker 's diverticle local oesophageal disease ( oesophageal stricture , oesophageal varix , previous oesophageal surgery past 6 month study inclusion , pharyngeal pouch ) patient receive haemodialysis patient know bleeding diatheses bleed disorder know patient 's history patient haematocrit &lt; = 25 % despite preoperative transfusion renal insufficiency ( serum creatinine &gt; 130 Âµmol/l &gt; 1.5 mg/dl ) oliguria anuria impair hepatic function define Mayo EndStage Liver Disease ( MELD ) &gt; 10 liver cirrhosis ChildPugh B C additional contraindication investigational product</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>80 Years</maximum_age>
	<verification_date>December 2016</verification_date>
	<keyword>PVR</keyword>
	<keyword>HES 130</keyword>
	<keyword>pancreatic head</keyword>
	<keyword>goal-directed</keyword>
	<keyword>intraoperative PVR elective surgery pancreatic head</keyword>
</DOC>